Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries
Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries. A Randomized Controlled Clinical Trial.
Insel Gruppe AG, University Hospital Bern
304 participants
Jan 6, 2023
INTERVENTIONAL
Conditions
Summary
The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.
Eligibility
Inclusion Criteria4
- Thoracoscopic extra-anatomical lung resection (surgical lung biopsy)
- Thoracoscopic pleural biopsy
- Signed consent
- Age of majority
Exclusion Criteria5
- Anatomical resection
- Empyema
- Pleural effusion
- Pleurodesis
- Vulnerable persons (Pregnant women, Children and adolescents)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Chest tube removal is a standard bedside intervention after lung resections. Its time point is normally defined according a traditional standard airleak threshold. Traditionally, in our department this threshold will be respected not earlier than 1 day after the operation. The patients of the study group are getting their chest tube removed according to our current airleak protocol (Flow \<20 mL/ min on digital suction device) but already in the operating room after wound closure (POD 0). If airleak is persisting than chest tube removal will be performed according to the traditional protocol not earlier than on postoperative day 1 (POD 1).
Chest tube removal according to traditional standard protocol not earlier than on postoperative day 1 (POD 1).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04670523